Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

NPS Pharmaceuticals

Inc., 30 College Street / Suite 301

Toronto

Canada

Name/email consistency: high

NPS Pharmaceuticals, Inc., 30 College Street / Suite 301, Toronto, Canada. 2002 - 2006
NPS Pharmaceuticals, Inc., Toronto, Ontario, Canada. 2004 - 2006
NPS Pharmaceuticals, Inc., 420 Chipeta Way, Salt Lake City, USA. 1998 - 2004

The parathyroid polyhormone hypothesis revisited. Nemeth, E.F. Kidney Int. Suppl. (2006) [Pubmed]
Misconceptions about calcimimetics. Nemeth, E.F. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
Calcimimetic and calcilytic drugs: just for parathyroid cells?. Nemeth, E.F. Cell. Calcium (2004) [Pubmed]
Summary--calcium receptors: potential targets for novel treatments for skeletal disease. Nemeth, E.F. J. Musculoskelet. Neuronal. Interact (2004) [Pubmed]
Pharmacological regulation of parathyroid hormone secretion. Nemeth, E.F. Curr. Pharm. Des. (2002) [Pubmed]
The search for calcium receptor antagonists (calcilytics). Nemeth, E.F. J. Mol. Endocrinol. (2002) [Pubmed]
Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. Nemeth, E.F., Delmar, E.G., Heaton, W.L., Miller, M.A., Lambert, L.D., Conklin, R.L., Gowen, M., Gleason, J.G., Bhatnagar, P.K., Fox, J. J. Pharmacol. Exp. Ther. (2001) [Pubmed]
Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Nemeth, E.F., Steffey, M.E., Hammerland, L.G., Hung, B.C., Van Wagenen, B.C., DelMar, E.G., Balandrin, M.F. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]